Answers are grounded in this paper and cite their sources.
The purpose of the current research aimed to evaluate the in vivo pharmacokinetics parameters of the formulated cilnidipine nanocrystals (CLND NCs) after oral dosing in comparison to orally CLND dispersion. Cilnidipine is a Ca+2 channel blocker applied to control elevated blood pressure and its vascular prognosis. The solvent-anti-solvent method was utilized to prepare CLND NCs.The bioavailability parameters were measured in male Westar rats (n = 12), and each rat weighed between 200 ±20
No takes yet. Share an insight, caveat, or question.
Hazzaa et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: